| WHO consolidated guidelines on tuberculosis World Health Organization World Health Organization, 2019 | 326 | 2019 |
| Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF GJ Churchyard, WS Stevens, LD Mametja, KM McCarthy, V Chihota, ... The Lancet Global Health 3 (8), e450-e457, 2015 | 248 | 2015 |
| The economic burden of TB diagnosis and treatment in South Africa N Foster, A Vassall, S Cleary, L Cunnama, G Churchyard, E Sinanovic Social science & medicine 130, 42-50, 2015 | 178 | 2015 |
| Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa E Sinanovic, K Floyd, L Dudley, V Azevedo, R Grant, D Maher The international journal of tuberculosis and lung disease 7 (9), S56-S62, 2003 | 150 | 2003 |
| Reference case for estimating the costs of global health services and interventions A Vassall, S Sweeney, J Kahn, G Gomez Guillen, L Bollinger, E Marseille, ... Global Health Cost Consortium, 2017 | 140 | 2017 |
| Preparing for HPV vaccination in South Africa: key challenges and opinions J Harries, J Moodley, MA Barone, S Mall, E Sinanovic Vaccine 27 (1), 38-44, 2009 | 126 | 2009 |
| Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting AM Mandalakas, AC Hesseling, RP Gie, HS Schaaf, BJ Marais, ... Thorax 68 (3), 247-255, 2013 | 115 | 2013 |
| Using top‐down and bottom‐up costing approaches in LMICs: The case for using both to assess the incremental costs of new technologies at scale L Cunnama, E Sinanovic, L Ramma, N Foster, L Berrie, W Stevens, ... Health economics 25, 53-66, 2016 | 110 | 2016 |
| Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis–a systematic review of global literature with focus on South Africa T Kastien-Hilka, A Abulfathi, B Rosenkranz, B Bennett, M Schwenkglenks, ... Health and quality of life outcomes 14, 1-13, 2016 | 94 | 2016 |
| Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation A Vassall, M Siapka, N Foster, L Cunnama, L Ramma, K Fielding, ... The Lancet Global Health 5 (7), e710-e719, 2017 | 90 | 2017 |
| Achieving universal access to sexual and reproductive health services: the potential and pitfalls for contraceptive services in South Africa N Lince-Deroche, M Pleaner, C Morroni, S Mullick, C Firnhaber, J Harries, ... South African Health Review 2016 (1), 95-108, 2016 | 82 | 2016 |
| Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa HP Hausler, E Sinanovic, L Kumaranayake, P Naidoo, H Schoeman, ... Bulletin of the World Health Organization 84 (7), 528-536, 2006 | 80 | 2006 |
| The performance of different models of primary care provision in Southern Africa A Mills, N Palmer, L Gilson, D McIntyre, H Schneider, E Sinanovic, ... Social science & medicine 59 (5), 931-943, 2004 | 71 | 2004 |
| Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa E Sinanovic, L Ramma, A Vassall, V Azevedo, L Wilkinson, N Ndjeka, ... The international journal of tuberculosis and lung disease 19 (2), 172-178, 2015 | 70 | 2015 |
| The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa E Sinanovic, J Moodley, MA Barone, S Mall, S Cleary, J Harries Vaccine 27 (44), 6196-6202, 2009 | 70 | 2009 |
| Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis K Schnippel, C Firnhaber, R Berhanu, L Page-Shipp, E Sinanovic Journal of Antimicrobial Chemotherapy 72 (7), 1871-1879, 2017 | 65 | 2017 |
| Health-related quality of life in South African patients with pulmonary tuberculosis T Kastien-Hilka, B Rosenkranz, E Sinanovic, B Bennett, ... PloS one 12 (4), e0174605, 2017 | 64 | 2017 |
| Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa L Ramma, H Cox, L Wilkinson, N Foster, L Cunnama, A Vassall, ... The international journal of tuberculosis and lung disease 19 (12), 1513-1519, 2015 | 58 | 2015 |
| Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa E Sinanovic, L Kumaranayake Cost Effectiveness and Resource Allocation 4, 1-10, 2006 | 55 | 2006 |
| Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models M Jit, N Demarteau, E Elbasha, G Ginsberg, J Kim, N Praditsitthikorn, ... BMC medicine 9, 1-9, 2011 | 54 | 2011 |
